The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Trastuzumab administration in HER2-postive gastric or GEJ cancer: Analysis of clinical practice.
Anuj Kishor Patel
No relevant relationships to disclose
Michael K. Gibson
No relevant relationships to disclose
James Ohr
No relevant relationships to disclose
David Friedland
No relevant relationships to disclose
James D. Luketich
No relevant relationships to disclose
Ryan M. Levy
No relevant relationships to disclose
Jon M. Davison
No relevant relationships to disclose
Aatur D. Singhi
No relevant relationships to disclose
Reetesh K. Pai
No relevant relationships to disclose
Weijing Sun
No relevant relationships to disclose